Journal of Thyroid Research最新文献

{"title":"Lack of Association between Poor Glycemic Control in T2DM and Subclinical Hypothyroidism.","authors":"Pragya Sharma,&nbsp;Rashmi Sinha,&nbsp;Anupa Prasad,&nbsp;J K Mitra","doi":"10.1155/2020/8121395","DOIUrl":"https://doi.org/10.1155/2020/8121395","url":null,"abstract":"<p><strong>Background: </strong>Hypothyroidism is a highly prevalent and multifactorial disorder and has been implicated in the causation of dyslipidemia, dermatological diseases, atherosclerosis, and myocardial dysfunction, as well as endothelial dysfunction. The relationship between subclinical hypothyroidism and type 2 diabetes mellitus is not well established. In the present study, we attempt to find out the prevalence of subclinical hypothyroidism in type 2 diabetes mellitus and its association with glycemic control.</p><p><strong>Materials and methods: </strong>This was an observational study in which 205 consecutive patients of T2DM visiting the outpatient department of medicine were recruited. Serum TSH, free thyroxine, free triiodothyronine, and lipid profile, as well as HbA1c assays, were done in the study participants, and they were categorized into three groups by HbA1c: <7%, 7-9%, and >9%.</p><p><strong>Results: </strong>There is a high prevalence of subclinical hypothyroidism in type 2 DM patients. Mean HbA1c in diabetics without SCH was 7.89%, whereas it was 8.33% in diabetics with SCH. This difference was statistically not significant. TSH was not found to be significantly associated with HbA1c.</p><p><strong>Conclusion: </strong>High prevalence of SCH in T2DM patients suggests that there is a need for regular follow-up to check the progression of SCH to overt hypothyroidism. High serum TSH is not a predictor of poor glycemic control.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"8121395"},"PeriodicalIF":2.1,"publicationDate":"2020-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8121395","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38411514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Tumor Volume Kinetic Analyses Might Explain Excellent Prognoses in Young Patients with Papillary Thyroid Carcinoma.","authors":"Toshihiko Kasahara,&nbsp;Akira Miyauchi,&nbsp;Yasuhiro Ito,&nbsp;Takumi Kudo,&nbsp;Hiroo Masuoka,&nbsp;Takuya Higashiyama,&nbsp;Mitsuru Ito,&nbsp;Minoru Kihara,&nbsp;Akihiro Miya","doi":"10.1155/2020/4652767","DOIUrl":"https://doi.org/10.1155/2020/4652767","url":null,"abstract":"<p><strong>Introduction: </strong>Young patients with papillary thyroid carcinoma (PTC) generally have excellent prognoses despite their often-advanced disease status. The reasons for this excellent prognosis are poorly understood.</p><p><strong>Objective: </strong>To investigate the natural history of PTC in young patients, we compared the observed tumor volume-doubling rate (TV-DR) with the hypothetical tumor volume-doubling rate (hTV-DR) before presentation in young PTC patients. DR is an inverse of the doubling time and indicates the number of doublings that occur in a unit of time. A negative value indicates the number of times the volume is reduced by half per unit time.</p><p><strong>Methods: </strong>We enrolled 20 patients with the following characteristics: age ≤19 years, diagnosed with PTC according to the cytology results between 2013 and 2018 and followed-up with periodical ultrasound examinations for ≥3 months before surgery for various reasons. Seventeen patients later underwent surgery confirming the diagnosis. We calculated TV-DRs using serial measurements of tumor diameters after presentation and hTV-DRs using tumor diameters and patients' age at presentation, assuming that a single cancer cell was present at the patient's birth and that the tumor grew at a constant rate. These values indicate the lowest growth rates necessary for a single cancer cell to achieve the full tumor size at presentation.</p><p><strong>Results: </strong>Thirteen patients had positive TV-DRs (/year) ranging from 0.09 to 1.89, indicating tumor growth, and the remaining seven patients had negative values (-0.08 to -1.21), indicating regression. The median TV-DR was 0.29. The hTV-DRs (1.48-2.66, median 1.71) were significantly larger than the TV-DRs (<i>p</i> < 0.001), indicating much faster growth before presentation.</p><p><strong>Conclusions: </strong>These data suggest that deceleration of tumor growth had already occurred at presentation in the majority of the cases. This might explain why disease-specific survival is excellent despite frequent findings of advanced disease in young patients with PTC.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"4652767"},"PeriodicalIF":2.1,"publicationDate":"2020-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/4652767","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38213366","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Possible Effects of Perchlorate Contamination of Drinking Water on Thyroid Health.","authors":"Sunny P Orathel,&nbsp;Ronnie Thomas,&nbsp;N Chandramohanakumar,&nbsp;Joy Job Kulavelil,&nbsp;Krishnapillai Girish Kumar,&nbsp;Vadayath Usha Menon,&nbsp;P Jayaprakash,&nbsp;Sajitha Krishnan,&nbsp;P S Manju,&nbsp;Shaiju Param,&nbsp;M G Rajamanickam,&nbsp;U G Unnikrishnan,&nbsp;Joe Thomas,&nbsp;Ponnu Jose","doi":"10.1155/2020/5208657","DOIUrl":"https://doi.org/10.1155/2020/5208657","url":null,"abstract":"<p><strong>Background: </strong>Perchlorate is an anion that occurs as a contaminant in groundwater. It originates from the improper disposal of ammonium perchlorate, a component of rocket fuel. The objective of this study was to explore whether the exposure to perchlorate in drinking water had an impact on the thyroid function of the population residing near an ammonium perchlorate plant in Kerala. <i>Methodology</i>. Using an ecological study design, we compared the serum levels of thyroid-stimulating hormone, thyroxine, and thyroid peroxidase antibodies among a representative sample of 289 study subjects from the area surrounding the ammonium perchlorate enrichment plant to 281 study subjects in a control area.</p><p><strong>Results: </strong>The perchlorate concentration in the groundwater varied from 1600 ppb to 57,000 ppb in the 10 samples from the contaminated area and was below 24 ppb in all locations in the control area. No significant differences were found in the mean serum TSH concentration and mean T4 levels between the subjects from the contaminated area and the control area. On regression analysis, perchlorate contamination was not found to be a significant predictor of TSH.</p><p><strong>Conclusion: </strong>This study did not find any significant association between perchlorate in drinking water and changes in thyroid hormone levels. Our findings indicate the need for further investigation of this hypothesis using urinary perchlorate as a measure of individual exposure.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"5208657"},"PeriodicalIF":2.1,"publicationDate":"2020-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5208657","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37977548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diagnosis and Management of Graves' Disease in Thailand: A Survey of Current Practice.","authors":"Chutintorn Sriphrapradang","doi":"10.1155/2020/8175712","DOIUrl":"10.1155/2020/8175712","url":null,"abstract":"<p><strong>Background: </strong>The data on clinical practice patterns in the evaluation and management of Graves' disease (GD) are limited in Asia. The aims of this survey were to report the current practices in the management of GD in Thailand and to examine any international differences in the management of GD.</p><p><strong>Methods: </strong>Members of the Endocrine Society of Thailand who were board certified in endocrinology (<i>N</i> = 392) were invited to participate in an electronic survey on the management of GD using the same index case and questionnaire as in previous North American and European surveys.</p><p><strong>Results: </strong>One hundred and twenty responses (30.6%) from members were included. TSH receptor antibody measurement (29.2%), thyroid ultrasound (6.7%), and isotopic studies (5.9%) were used less frequently to confirm the etiology compared with those in North American and European surveys. Treatment with an antithyroid drug (ATD) was the preferred first choice of therapy (90.8%). Methimazole at 10-15 mg/day with a beta-blocker was the initial treatment of choice. The preferred ATD in pregnancy was propylthiouracil in the first trimester and methimazole in the second and third trimesters, which was similar to the North American and European surveys.</p><p><strong>Conclusion: </strong>Ultrasound and isotopic studies will be requested only by a small proportion of Thai endocrinologists. Higher physician preference for ATD is similar to Europe, Latin America, and other Asian countries. Geographical differences in the use of ATD, radioactive iodine, and thyroidectomy exist.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"8175712"},"PeriodicalIF":1.7,"publicationDate":"2020-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7238361/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37977026","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Distribution and Prognostic Significance of Estrogen Receptor <i>α</i> (ER<i>α</i>), Estrogen Receptor <i>β</i> (ER<i>β</i>), and Human Epidermal Growth Factor Receptor 2 (HER-2) in Thyroid Carcinoma.","authors":"Anjali Mishra,&nbsp;Niraj Kumari,&nbsp;Chandan Kumar Jha,&nbsp;Raouef Ahamed Bichoo,&nbsp;Shravan Kumar Mishra,&nbsp;Narendra Krishnani,&nbsp;Saroj Kanta Mishra","doi":"10.1155/2020/6935724","DOIUrl":"https://doi.org/10.1155/2020/6935724","url":null,"abstract":"<p><strong>Purpose: </strong>The primary aim of this study was to determine the incidence of estrogen receptor <i>α</i> (ER<i>α</i>), estrogen receptor <i>β</i> (ER<i>β</i>), and human epidermal growth factor receptor 2 (HER-2) expression in various subtypes of thyroid carcinoma (TC) of follicular origin and the secondary aim was to correlate the expression with various clinicopathologic prognostic factors.</p><p><strong>Methods: </strong>Immunohistochemistry analysis was performed on archival paraffin-embedded tissue sections (1991-2016). ER<i>α</i>, ER<i>β,</i> and HER-2 expressions were correlated with clinicopathologic prognostic factors, disease recurrence, and overall survival (OS).</p><p><strong>Results: </strong>A total of 264 TC patients were included in the study. Incidences of ER<i>α</i>, ER<i>β,</i> and HER-2 were 8.1 vs 16.3 vs 13.9% (<i>p</i>=0.15), 26.6 vs 11.5 vs 36.1% (<i>p</i>=0.002), and 12.9 vs 2.9 vs 0% (<i>p</i>=0.003) in papillary thyroid carcinoma (PTC), follicular thyroid carcinoma (FTC), and poorly differentiated thyroid carcinoma (PDTC), respectively. Overall ER<i>α</i> had significant correlation with distant metastases (0.038) and in case of PDTC with multicentricity (<i>p</i>=0.037). ER<i>β</i> had significant correlation with lymph node metastases (<i>p</i>=0.023) in FTC. HER-2 correlated with tumor size (<i>p</i>=0.027) only on univariate analysis. OS did not correlate with expression of any receptor.</p><p><strong>Conclusion: </strong>ER<i>α</i>, ER<i>β,</i> and HER-2 have differential expression and prognostic implications in different TC subtypes.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"6935724"},"PeriodicalIF":2.1,"publicationDate":"2020-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/6935724","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37952380","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Bethesda System for Reporting Thyroid Cytopathology: A Cytohistological Study.","authors":"Bakiarathana Anand,&nbsp;Anita Ramdas,&nbsp;Marie Moses Ambroise,&nbsp;Nirmal P Kumar","doi":"10.1155/2020/8095378","DOIUrl":"https://doi.org/10.1155/2020/8095378","url":null,"abstract":"<p><strong>Introduction: </strong>The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) is a significant step to standardize the reporting of thyroid fine needle aspiration (FNA). It has high predictive value, reproducibility, and improved clinical significance.</p><p><strong>Aim: </strong>The study was aimed to evaluate the diagnostic utility and reproducibility of \"TBSRTC\" at our institute. <i>Methods and Material</i>. The study included 646 thyroid FNAs which were reviewed by three pathologists and classified according to TBSRTC. Cytohistological correlation was done for 100 cases with surgical follow-up and the sensitivity, specificity, positive predictive value, negative predictive value, diagnostic accuracy, and risk of malignancy (ROM) were calculated. The interobserver variation among three pathologists was also assessed.</p><p><strong>Results: </strong>The distribution of cases in various TBSRTC categories is as follows: I-nondiagnostic 13.8%, II-benign 75.9%, III-atypia of undetermined significance (AUS)/follicular lesion of undetermined significance (FLUS) 1.2%, IV-follicular neoplasm (FN)/suspicious for follicular neoplasm (SFN) 3.7%, V-suspicious for malignancy (SM) 2.6%, and VI-malignant 2.8%. The sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy are 72.4%, 94.3%, 84%, 89.2%, and 87.9%, respectively. The ROM of various TBSRTC categories were II-8.5%; III-66.7%; IV-63.6%; and V and VI-100%. Cohen's Weighted Kappa score was 0.99 which indicates almost perfect agreement among the three pathologists.</p><p><strong>Conclusions: </strong>Our study substantiates greater reproducibility among pathologists using TBSRTC to arrive at a precise diagnosis with an added advantage of predicting the risk of malignancy which enables the clinician to plan for follow-up or surgery and also the extent of surgery.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"8095378"},"PeriodicalIF":2.1,"publicationDate":"2020-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8095378","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37887049","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Prognostic Significance of Thyroglobulin Antibodies in Differentiated Thyroid Cancer.","authors":"Jordi L Reverter,&nbsp;Irene Rosas-Allende,&nbsp;Carlos Puig-Jove,&nbsp;Carles Zafon,&nbsp;Ana Megia,&nbsp;Ignasi Castells,&nbsp;Eduarda Pizarro,&nbsp;Manel Puig-Domingo,&nbsp;M Luisa Granada","doi":"10.1155/2020/8312628","DOIUrl":"https://doi.org/10.1155/2020/8312628","url":null,"abstract":"Objective To investigate whether variations in thyroglobulin autoantibodies (TgAb) are related to the recurrence or persistence of differentiated thyroid carcinoma (DTC) and may therefore be useful as surrogate tumor markers. Design and Methods. We retrospectively studied 98 subjects (83 women, 47 ± 15 years old) from an initial cohort of 1017 patients treated for DTC in five hospitals, with positive TgAb at any time during the follow-up. Patients presented five different patterns of evolution of serum TgAb concentrations: (1) stable positive TgAb, (2) de novo appearance, (3) an increase of more than 50%, (4) TgAb levels from positive to negative, and (5) a decrease of more than 50%. Results In the group of 11 patients with stable TgAb, four cases presented persistence of the disease with structural incomplete response. In the group of 22 patients with sustained increasing trend rising more than 50% or de novo detectable TgAb levels, three patients were diagnosed with structural incomplete response. There was no evidence of recurrence or persistence of the disease in any of the 65 patients who showed a significant decrease in (n = 35) or disappearance of (n = 30) TgAb. Conclusions Our results suggest that not only the appearance of a significant increase in TgAb but also stable concentrations of TgAb should be regarded as a sufficient risk condition for an active search for recurrent or persistent disease. Conversely, a significant decrease in TgAb levels can represent a good prognostic sign.","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"8312628"},"PeriodicalIF":2.1,"publicationDate":"2020-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8312628","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37887050","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lymph Node Metastasis and Extrathyroidal Extension in Papillary Thyroid Microcarcinoma in Cyprus: Suspicious Subcentimeter Nodules Should Undergo FNA When Multifocality is Suspected.","authors":"Christos Papaioannou, Demetris Lamnisos, Katerina Kyriacou, Theodoros Lyssiotis, Vasilis Constantinides, Savvas Frangos, Aliki Economides, Panayiotis A Economides","doi":"10.1155/2020/3567658","DOIUrl":"10.1155/2020/3567658","url":null,"abstract":"<p><strong>Objective: </strong>To determine the prevalence of lymph node (LN) metastasis and extrathyroidal extension (ETE) in patients with papillary thyroid microcarcinoma (PTMC) in Cyprus and to evaluate the role of preoperative ultrasound (U/S) examination.</p><p><strong>Methods: </strong>A retrospective study of 102 patients who underwent thyroidectomy for PTMC in a 2-year period. Preoperatively, all patients had a thyroid and neck U/S examination with LN mapping. Tumor size according to the largest diameter, number of foci, LN metastasis, and ETE data was collected from the histopathological report and was compared to the preoperative U/S reports.</p><p><strong>Results: </strong>LN metastasis was present in 23.5% of patients. 15.7% had central, 3.9% had lateral, and 3.9% had both central and lateral LN metastasis. ETE was present in 27.5% of patients. 21.6% had multifocal disease, and in this group, 40.9% had LN metastasis and 36.4% had ETE. Multifocality (<i>p</i> = 0.03), size of tumor (<i>p</i> = 0.05), and ETE (<i>p</i> ≤ 0.001) were significantly associated with LN metastasis. The prevalence of LN metastasis in multifocal PTMC ≤5 mm was the same with multifocal PTMC >5 mm. The preoperative U/S sensitivity for the suspicious lateral neck and central LN was 100%, and the specificity was 100%. The preoperative U/S sensitivity for nodules suspicious for ETE was 53.6%, and the specificity was 100%.</p><p><strong>Conclusion: </strong>The presence of LN metastasis and ETE in our PTMC patients in Cyprus is frequent. Neck U/S mapping is a highly reliable and accurate tool in identifying metastatic nodes. LN metastasis is associated with ETE and multifocality. Suspicious subcentimeter nodules should undergo FNA irrespective of size when multifocality is suspected.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"3567658"},"PeriodicalIF":1.7,"publicationDate":"2020-03-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7128046/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37887048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Microscopic Positive Tumor Margin Increases Risk for Disease Persistence but Not Recurrence in Patients with Stage T1-T2 Differentiated Thyroid Cancer.","authors":"Olfat Kamel Hasan,&nbsp;Sarah De Brabandere,&nbsp;Irina Rachinsky,&nbsp;David Laidley,&nbsp;Danielle MacNeil,&nbsp;Stan Van Uum","doi":"10.1155/2020/5287607","DOIUrl":"https://doi.org/10.1155/2020/5287607","url":null,"abstract":"<p><strong>Introduction: </strong>Differentiated thyroid cancer (DTC) has an overall excellent prognosis. Patients who develop recurrent disease have a more unfavorable disease course than those with no recurrence. Higher recurrence rates are seen with incomplete surgical resection and gross positive margins. It is unclear whether microscopic positive margin affects disease recurrence rates as much as grossly positive margin. <i>Aim of the Study</i>. To assess whether microscopic positive margin is an independent predictor of disease recurrence in patients with overall low-risk DTC. <i>Patients and Methods</i>. We conducted a retrospective single-center institutional review of 1,583 consecutive patients' charts from 1995-2013 using the Canadian Thyroid Cancer Consortium Registry. We included adult patients with nonmetastasizing T1 and T2 DTC with a minimum of three years follow-up. Univariate and multivariate analyses were used to study factors that may influence the risk of persistent/recurrent disease. Strict definitions of persistent versus recurrent disease were applied.</p><p><strong>Results: </strong>963 patients (152 men and 811 women) were included in the study with a mean age of 46 years. Microscopic positive margins were present in 12% of the specimens and were associated with an increased rate of persistent disease (8% versus 2% in the controls) but not with an increased risk of recurrent disease (1% in both groups). T2 tumors had a significantly higher incidence of positive margins than T1 tumors (48% versus 36%) and significantly higher nodal staging.</p><p><strong>Conclusions: </strong>Microscopic positive margin in the histopathology report in patients with low-risk DTC was associated with a higher rate of persistent disease but did not increase the risk of disease recurrence. A close follow-up of biomarkers and occult residual cancerous lesions is needed, especially in the first year. Further studies are needed to determine whether additional therapeutic measures to prevent recurrence are indicated in T1 and T2 DTC with positive microscopic surgical margins.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2020 ","pages":"5287607"},"PeriodicalIF":2.1,"publicationDate":"2020-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5287607","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37925359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Hospital-Based Study of Iodine Nutrition Status of Breastfeeding Mothers in Bangladesh.","authors":"Jobaida Naznin,&nbsp;Mohammad Fariduddin,&nbsp;Mashfiqul Hasan,&nbsp;Mohammad Atiqur-Rahman,&nbsp;Nusrat Sultana,&nbsp;Mohammad Anowar-Hossain,&nbsp;Sharmin Chowdhury,&nbsp;Muhammad Abul Hasanat","doi":"10.1155/2019/9896159","DOIUrl":"https://doi.org/10.1155/2019/9896159","url":null,"abstract":"<p><p>Adequacy of iodine nutrition status in breastfeeding mothers is vital in preventing iodine deficiency disorder (IDD) in neonates and children. The aim of the study was to assess urinary iodine status in breastfeeding mothers attending Bangabandhu Sheikh Mujib Medical University (BSMMU) hospital in Bangladesh. In this cross-sectional study carried out from January 2014 to January 2015, urinary iodine (UI; <i>μ</i>gm/L) level of 266 mothers (age 26.6 ± 4.7 years (mean ± SD), exclusively breastfeeding: 132 and nonexclusively breastfeeding: 134), recruited on consecutive basis from BSMMU outdoor and indoor, were measured in spot urine following the wet digestion method. Median UI in the participants was 298.6 (interquartile range, IQR 206.6-454.9) <i>μ</i>gm/L and only 6.4% lactating mother had low UI (i.e. <100 <i>μ</i>gm/L). There was no difference of median UI in relation to exclusive or nonexclusive breast feeding, presence of goiter, parity, and age of breastfed baby (<i>p</i>=ns for all). But median UI was higher in older subjects (≥30 years vs. <30 years: 364.4 (228.4-529.9) vs. 283.7 (205.4-434.0); median (IQR) <i>p</i>=0.040)), with good socioeconomic condition (good vs. average or less: 328.2 (243.8-510.0) vs. 274.4 (200.0-433.3); median (IQR); <i>p</i>=0.020), and in those who are aware regarding the importance of iodine (aware vs. unaware: 316.6 (225.2-506.3) vs. 270.1 (196.0-407.2); median (IQR); <i>p</i>=0.018). The proportion of participants with UI < 100 <i>μ</i>gm/L was similar in all the groups. Logistic regressions to predict deficient UI status revealed none of the variables to be an independent predictor. This study indicates that deficient iodine nutrition status in Bangladeshi breastfeeding mothers is not frequent at present.</p>","PeriodicalId":17394,"journal":{"name":"Journal of Thyroid Research","volume":"2019 ","pages":"9896159"},"PeriodicalIF":2.1,"publicationDate":"2019-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2019/9896159","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41204113","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}